<DOC>
	<DOCNO>NCT02788682</DOCNO>
	<brief_summary>Introduction : Vitamin D bind protein ( VDBP ) potential modulator immune response associate clinical progression many disease . Our aim ass influence baseline 25-hydroxyvitamin D level VDBP single nucleotide polymorphism ( SNPs ) , rs4588 ( C &gt; A ) rs7041 ( G &gt; T ) , baseline clinical parameter response interferon base therapy chronic Hepatitis C patient Egypt . Methodology : Genotyping perform RFLP ( Restriction Fragment Length Polymorphism ) treatment naïve Hepatitis C patient healthy control . Vitamin D level assess ELISA . HCV RNA quantification perform PCR assess therapy outcome .</brief_summary>
	<brief_title>Association Vitamin D Binding Protein Polymorphisms With Response HCV Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Age ≥ 18 year ≤ 60 year , fast blood sugar le 115 mg/dl 20 % upper normal limit ( 140 mg/dl ) , HBA1C ≤ 7.5 % diabetic patient , normal serum creatinine , normal thyroid stimulate hormone level , negative Hepatitis B surface antigen , hemoglobin ≥ 12g/dl male ≥ 11g/dl female , total leukocyte ≥ 3,500/mm3 , ANC ≥ 1500/mm3 , platelet ≥ 100,000/mm3 , presence HCV RNA PCR elevate liver enzymes within precede 6 month patient F1 fibrosis stage . hypersensitivity interferon ribavirin , decompensated liver cirrhosis ( presence ascites , esophageal varix hepatic encephalopathy ) , hepatocellular carcinoma , body mass index &gt; 35 Kg/m2 vitamin D supplementation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>VDBP</keyword>
	<keyword>single nucleotide polymorphism ( SNPs )</keyword>
	<keyword>interferon base therapy</keyword>
	<keyword>Egypt</keyword>
</DOC>